I've been thinking about for the last quarter or two as to when that good public report will come. And I don't think it's any time soon. Because, obviously, nothing big has happened. We get Q3 reporting. I don't doubt it. MAYBE something in a forward thinking portion of the report. MAYBE Q4/Year End. MAYBE something in a forward thinking portion of the report. If they can get some clinical trials up and running this final quarter of the year then that's a better chance of a good public report. The dream sequence is clinical trials up and running Q4 2021 and money starts coming in Q1 2022. If by some freak luck that happens then maybe a reverse split won't be needed.